ESC 365 - Image-based cardiac safety assessment, a novel approach to complement in vitro hiPSC-CM electrophysiology studies

CBS PREMIUM ACCESS

Image-based cardiac safety assessment, a novel approach to complement in vitro hiPSC-CM electrophysiology studies

Session: Late-Breaking Science - Poster session 1

Topic: Drugs, Drug Targets

Speaker: Miss B. Szabo (Maastricht, NL)

Event: Frontiers in CardioVascular Biomedicine 2022

Congress Presentation

Add to my library

About the speaker

Miss Brigitta Rita Szabo

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))

1 presentation

0 follower

4 more presentations in this session

Deep molecular characterization of human induced pluripotent stem cell-derived atrial cardiomyocytes

Speaker: Miss M. Casini (Valencia, ES)

Ischemia-selective protection against cardiac ischemia/reperfusion injury by malonate

Speaker: Doctor H. Prag (Cambridge, GB)

Effect of angiotensin receptor neprilysin inhibitor and empagliflozin on systemic inflammation and scar remodeling in a swine model of chronic myocardial infarction

Speaker: Miss D. Martinez-Falguera (Badalona, ES)

M1 activated macrophages cause cardiac arrhythmia - an hiPSC-based in vitro model of inflammation associated atrial fibrillation

Speaker: Mr T. Hutschalik (Maastricht, NL)

Access the full session

Late-Breaking Science - Poster session 1

Speakers: Miss B. Szabo, Miss M. Casini, Doctor H. Prag, Miss D. Martinez-Falguera, Mr T. Hutschalik

About the event

Frontiers in CardioVascular Biomedicine 2022

29 April - 1 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources